AbCellera Biologics Inc. ABCL Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s cash provided by (used in) financing activity, including discontinued operation?
- AbCellera Biologics Inc. (ABCL) reported cash provided by (used in) financing activity, including discontinued operation of $7.19M in Q1 2026.
- How has AbCellera Biologics Inc.'s cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- AbCellera Biologics Inc.'s cash provided by (used in) financing activity, including discontinued operation increased by 20.5% year-over-year, from $5.97M to $7.19M.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.